Walgreens Boots Alliance-Exploring Analyst Estimates for Walgreens (WBA) Q1 Earnings, Beyond Revenue and EPS

Earnings and Revenue Expectations - Wall Street analysts expect Walgreens Boots Alliance (WBA) to post quarterly earnings of $0.37 per share, indicating a year-over-year decline of 43.9% [1] - Revenues are expected to be$ 37.1 billion, up 1.1% from the year-ago quarter [1] - The consensus EPS estimate for the quarter has been adjusted upward by 0.7% over the past 30 days, reflecting analysts' reassessment of initial projections [1] Importance of Earnings Revisions - Revisions to earnings projections are critical for predicting potential investor behaviors and short-term stock price performance [2] - Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and stock price performance [2] Key Metrics Analysis - Analysts forecast 'Revenues- U.S. Retail Pharmacy' to reach $29.19 billion, indicating a change of +0.9% from the prior-year quarter [4] - 'Revenues- International' is predicted to reach$ 5.91 billion, with a change of +1.4% from the prior-year quarter [4] - The consensus estimate for 'Revenues- U.S. Healthcare' stands at $2.04 billion, suggesting a change of +5.9% year over year [4] Detailed Revenue Breakdown - 'Revenues- U.S. Retail Pharmacy- Pharmacy' is expected to come in at$ 23.15 billion, indicating a change of +3.4% from the year-ago quarter [5] - 'Revenues- U.S. Retail Pharmacy- Retail' is forecasted to reach $6.31 billion, with a year-over-year change of -3.9% [5] Operating Income Projections - 'Adjusted operating income (loss)- U.S. Retail Pharmacy' is expected to reach$ 298.78 million, compared to the year-ago figure of $694 million [6] - 'Adjusted operating income (loss)- International' is projected to arrive at$ 165.99 million, compared to the year-ago value of $142 million [6]